Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12(2):332–45.
Article CAS PubMed Google Scholar
Watts AJB, Keller KH, Lerner G, et al. Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology. J Am Soc Nephrol. 2022;33(1):238–52.
Article CAS PubMed PubMed Central Google Scholar
Hengel FE, Dehde S, Lassé M, et al. Autoantibodies targeting nephrin in podocytopathies. N Engl J Med. 2024;391(5):422–33.
Article CAS PubMed Google Scholar
Kielstein JT, Termühlen L, Sohn J, Kliem V. Minimal change nephrotic syndrome in a 65-year-old patient following influenza vaccination. Clin Nephrol. 2000;54(3):246–8.
Yamashiro A, Uchida T, Ito S, Oshima N, Oda T, Kumagai H. Complete remission of minimal change disease following an improvement of lung Mycobacterium avium infection. Intern Med. 2016;55(18):2669–72.
Haruki A, Ishikawa E, Katayama K, et al. Spontaneous remission of adult-onset minimal change nephrotic syndrome associated with influenza B infection: a case report. BMC Nephrol. 2018;19(1):162.
Article PubMed PubMed Central Google Scholar
Chiba Y, Nagasawa T, Kin S, et al. Spontaneous remission of minimal change nephrotic syndrome in an elderly man. CEN Case Rep. 2021;10(2):301–7.
Article PubMed PubMed Central Google Scholar
Glassock RJ. Secondary minimal change disease. Nephrol Dial Transpl. 2003;18(Suppl 6):vi52–8.
Gauckler P, Matyjek A, Kapsia S, et al. Long-Term outcomes of Rituximab-Treated adult patients with podocytopathies. J Am Soc Nephrol. 2025;36(4):668–78.
Meyrier A. Treatment of idiopathic nephrosis by Immunophillin modulation. Nephrol Dial Transpl. 2003;18(Suppl 6):vi79–86.
Lin CY, Hsu HC. Histopathological and immunological studies in spontaneous remission of nephrotic syndrome after intercurrent measles infection. Nephron. 1986;42(2):110–5.
Article CAS PubMed Google Scholar
Liu LL, Qin Y, Cai JF, et al. Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome. Clin Immunol. 2011;139(3):314–20.
Article CAS PubMed Google Scholar
Reiser J, von Gersdorff G, Loos M, et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest. 2004;113(10):1390–7.
Article CAS PubMed PubMed Central Google Scholar
Cara-Fuentes G, Venkatareddy M, Verma R, et al. Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse. Pediatr Nephrol. 2020;35(10):1887–96.
Article PubMed PubMed Central Google Scholar
Novelli R, Benigni A, Remuzzi G. The role of B7-1 in proteinuria of glomerular origin. Nat Rev Nephrol. 2018;14(9):589–96.
Article CAS PubMed Google Scholar
Yu CC, Fornoni A, Weins A, et al. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med. 2013;369(25):2416–23.
Article CAS PubMed PubMed Central Google Scholar
Khullar B, Balyan R, Oswal N, et al. Interaction of CD80 with Neph1: a potential mechanism of podocyte injury. Clin Exp Nephrol. 2018;22(3):508–16.
Article CAS PubMed Google Scholar
Shimada M, Ishimoto T, Lee PY, et al. Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway. Nephrol Dial Transpl. 2012;27(1):81–9.
Ohl K, Eberhardt C, Spink C, et al. CTLA4 polymorphisms in minimal change nephrotic syndrome in children: a case-control study. Am J Kidney Dis. 2014;63(6):1074–5.
Article CAS PubMed Google Scholar
Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int. 1986;29(6):1215–23.
Article CAS PubMed Google Scholar
Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis. 2002;39(3):503–12.
Comments (0)